These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 4917131)

  • 1. An optimal zone of colistin activity with Serratia marcescens.
    Annear DI
    Med J Aust; 1970 Aug; 2(5):225-7. PubMed ID: 4917131
    [No Abstract]   [Full Text] [Related]  

  • 2. An unusual zone surrounding colistin discs in sensitivity tests of Serratia marcescens.
    Annear DI; Hudson JA
    Med J Aust; 1970 Apr; 1(17):840-1. PubMed ID: 4913361
    [No Abstract]   [Full Text] [Related]  

  • 3. Reliability of the colistin disk test in identification of Serratia marcescens and Serratia liquefaciens.
    von Graevenitz A; Zollinger-Iten J
    Eur J Clin Microbiol; 1987 Feb; 6(1):70-1. PubMed ID: 3032610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A highly mucoid isolate of Serratia marcescens.
    Annear DI; Bailey M; Grubb WB
    Pathology; 1973 Jul; 5(3):257-9. PubMed ID: 4583901
    [No Abstract]   [Full Text] [Related]  

  • 5. The combination of erythromycin and colistin against Serratia marcescens.
    Fothergill J; Smith JA
    J Antimicrob Chemother; 1981 Jun; 7(6):681. PubMed ID: 7019189
    [No Abstract]   [Full Text] [Related]  

  • 6. [Enrichment of auxotrophic mutants of Serratia marcescens by means of antibiotics].
    Stamminger G; Schwager M; Kaplan RW
    Arch Mikrobiol; 1970; 73(3):231-7. PubMed ID: 4922627
    [No Abstract]   [Full Text] [Related]  

  • 7. Antibiotic susceptibilities of Serratia marcescens and Enterobacter liquefaciens.
    Greenup P; Blazevic DJ
    Appl Microbiol; 1971 Sep; 22(3):309-14. PubMed ID: 4330312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity of the colistin-rifampicin combination against colistin-resistant, carbapenemase-producing Gram-negative bacteria.
    Nastro M; Rodríguez CH; Monge R; Zintgraff J; Neira L; Rebollo M; Vay C; Famiglietti A
    J Chemother; 2014 Aug; 26(4):211-6. PubMed ID: 24070502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of colistin and sorbitol for better isolation of Serratia marcescens in clinical samples.
    Grasso GM; D'Errico MM; Schioppa F; Romano F; Montanaro D
    Epidemiol Infect; 1988 Oct; 101(2):315-20. PubMed ID: 3053219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitivity studies on Serratia strains from clinical specimens.
    von Graevenitz A
    Chemotherapy; 1967; 12(4):215-25. PubMed ID: 4863818
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical studies on urinary tract infections caused by Serratia marcescens. I. Clinical and bacteriological studies on urinary tract infections caused by Serratia marcescens].
    Sakai S; Kumamoto Y
    Nihon Hinyokika Gakkai Zasshi; 1983 Apr; 74(4):467-84. PubMed ID: 6353020
    [No Abstract]   [Full Text] [Related]  

  • 12. [Urinary tract infections due to Serratia marcescens. I. Antimicrobial susceptibility patterns of clinical isolates of Serratia marcescens (author's transl)].
    Igari J; Kosakai N
    Jpn J Antibiot; 1977 Oct; 30(10):840-6. PubMed ID: 338940
    [No Abstract]   [Full Text] [Related]  

  • 13. In vitro activity of colistin sulfate against Enterobacteriaceae producing extended-spectrum β-lactamases.
    Ku YH; Lee MF; Chuang YC; Chen CC; Yu WL
    J Microbiol Immunol Infect; 2015 Dec; 48(6):699-702. PubMed ID: 24388585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Serratia marcescens infections. Bacteriological study, antibiogram, and clinical significance].
    Paredes L; Fernández M; Paredes M; Fuenzalida P; Paredes L
    Rev Med Chil; 1974 Feb; 102(2):109-17. PubMed ID: 4157414
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of methods for differentiating among Serratia marcescens isolated from clinical specimens.
    Roemisch E; Kocka FE
    Am J Clin Pathol; 1976 Jul; 66(1):96-100. PubMed ID: 779447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug resistance and R plasmid in clinical isolates of Serratia marcescens at Shinshu University Hospital.
    Kawakami Y; Okimura Y; Kanai M
    Jpn J Antibiot; 1988 May; 41(5):505-9. PubMed ID: 3063848
    [No Abstract]   [Full Text] [Related]  

  • 17. Isolation of Serratia marcescens on deoxyribonuclease-toluidine blue-cephalothin agar.
    Farmer JJ; Silva F; Williams DR
    Appl Microbiol; 1973 Jan; 25(1):151-2. PubMed ID: 4568885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinico-bacteriological study of 20 Serratia marcescens infections treated with amikacin].
    Pérez González F; Prendes Peláez P; Meana Fonseca JL; Martín Alvarez R
    Rev Clin Esp; 1981 Jun 15-30; 161(5-6):327-34. PubMed ID: 7027369
    [No Abstract]   [Full Text] [Related]  

  • 19. Serratia marcescens: biochemical characteristics, antimicrobial sensitivity and clinical significance.
    Puthucheary SD; Ngeow YF
    Malays J Pathol; 1981 Aug; 4():35-41. PubMed ID: 6764658
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of sodium fluorescein and plating medium on recovery of irradiated Escherichia coli and Serratia marcescens from aerosols.
    Dorsey EL; Berendt RF; Neff EL
    Appl Microbiol; 1970 Nov; 20(5):834-8. PubMed ID: 4922085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.